CD274 and neoplasm: All tumors were PD-L1+ (using the SP263 clone antibody) with a tumor proportion score (TPS; proportion of PD-L1+ tumor cells of 100 tumor cells) ranging from 1% to 90% and a CPS (number of PD-L1+ tumor and immune cells within 100 tumor cells) ranging from 5 to 100.